Bristol-Myers Squibb Co. v. Superior Court of Cal., San Francisco Cty.
Bristol-Myers Squibb Co. v. Superior Court of Cal., San Francisco Cty., 16-466
In a suit brought by plaintiffs, most of whom are not California residents, against Bristol-Myers Squibb Company (BMS) in California state court, alleging that the pharmaceutical company’s drug Plavix had damaged their health, the Supreme Court of California’s judgment concluding that BMS’s ‘wide ranging’ contacts with the State were enough to support a finding of specific jurisdiction over the claims brought by the nonresident plaintiffs, is reversed where California courts lack specific jurisdiction to entertain the nonresidents’ claims.
- Published 2017/06/19
- United States Supreme Court